These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7538177)

  • 21. Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells.
    Patel KP; Coyne CB; Bergelson JM
    J Virol; 2009 Nov; 83(21):11064-77. PubMed ID: 19710132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
    D'Cruz OJ; Haas GG
    Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.
    Shafren DR; Dorahy DJ; Ingham RA; Burns GF; Barry RD
    J Virol; 1997 Jun; 71(6):4736-43. PubMed ID: 9151867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
    Jimenez-Clavero MA; Escribano-Romero E; Ley V; Spiller OB
    J Gen Virol; 2005 May; 86(Pt 5):1369-1377. PubMed ID: 15831949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
    Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
    J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors.
    Bergelson JM; Modlin JF; Wieland-Alter W; Cunningham JA; Crowell RL; Finberg RW
    J Infect Dis; 1997 Mar; 175(3):697-700. PubMed ID: 9041347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echovirus 1 interaction with the isolated VLA-2 I domain.
    King SL; Cunningham JA; Finberg RW; Bergelson JM
    J Virol; 1995 May; 69(5):3237-9. PubMed ID: 7535868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
    Shafren DR; Williams DT; Barry RD
    J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions.
    Kramer B; Huber M; Kern C; Klingel K; Kandolf R; Selinka HC
    Virus Res; 1997 May; 48(2):149-56. PubMed ID: 9175253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The replication of certain Coxsackie B virus strains in CHO cells.
    Frisk G; Elfström T; Diderholm H
    J Virol Methods; 2001 Nov; 98(2):161-5. PubMed ID: 11576643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2.
    Shafren DR; Gardner J; Mann VH; Antalis TM; Suhrbier A
    J Virol; 1999 Sep; 73(9):7193-8. PubMed ID: 10438806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
    Spiller OB; Goodfellow IG; Evans DJ; Hinchliffe SJ; Morgan BP
    J Gen Virol; 2002 Jan; 83(Pt 1):45-52. PubMed ID: 11752699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
    van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
    Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
    Stuart AD; McKee TA; Williams PA; Harley C; Shen S; Stuart DI; Brown TD; Lea SM
    J Virol; 2002 Aug; 76(15):7694-704. PubMed ID: 12097583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral cell entry induced by cross-linked decay-accelerating factor.
    Shafren DR
    J Virol; 1998 Nov; 72(11):9407-12. PubMed ID: 9765499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD46 is a cellular receptor for human herpesvirus 6.
    Santoro F; Kennedy PE; Locatelli G; Malnati MS; Berger EA; Lusso P
    Cell; 1999 Dec; 99(7):817-27. PubMed ID: 10619434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of human colon cancer cells.
    Agrez MV; Shafren DR; Gu X; Cox K; Sheppard D; Barry RD
    Virology; 1997 Dec; 239(1):71-7. PubMed ID: 9426447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered BGMK cells for sensitive and rapid detection of enteroviruses.
    Huang YT; Yam P; Yan H; Sun Y
    J Clin Microbiol; 2002 Feb; 40(2):366-71. PubMed ID: 11825943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid raft- and SRC family kinase-dependent entry of coxsackievirus B into human placental trophoblasts.
    Delorme-Axford E; Sadovsky Y; Coyne CB
    J Virol; 2013 Aug; 87(15):8569-81. PubMed ID: 23720726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echoviruses bind heparan sulfate at the cell surface.
    Goodfellow IG; Sioofy AB; Powell RM; Evans DJ
    J Virol; 2001 May; 75(10):4918-21. PubMed ID: 11312365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.